Biota Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 57   

Articles published

BOTA 2.28 +0.09 (4.11%)
price chart
Biota Pharmaceuticals Inc.: Biota Pharmaceuticals to Host Conference Call to ...
ATLANTA, Sept. 15, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") announced today that it will host a conference call on Friday, September 26, 2014 at 9:00 a.m.
Biota Pharmaceuticals to Host Conference Call to Report Fourth Quarter and ...  MarketWatch
Related articles »  
Today's Watch List: Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), Oracle ...
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced that it will host a conference call on Friday, September 26, 2014 at 9:00 a.m.
Investor Alert:Biota Pharmaceuticals Inc (NASDAQ:BOTA) faces Investor ...
The Shareholders Foundation announces that an investigation on behalf of investors of Biota Pharmaceuticals Inc (NASDAQ:BOTA) shares was launched over potential securities laws violations by Biota Pharmaceuticals and certain of its directors and ...
Today's Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), Alnylam ...  Crazy Joys
Related articles »  
Investors Are Watching: MeetMe, Inc. (NASDAQ:MEET), Biota Pharmaceuticals ...
On 15 August MeetMe, Inc. (NASDAQ:MEET) announced that Jason Whitt has been appointed to the company's board of directors.
Big Movers: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Biota ...  Markets Insider
Related articles »  
Hot Stock List: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Biota ...
On 15 AUG Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Director Alexander J. Denner acquired 850,000 shares of Ariad Pharmaceuticals stock on the open market in a transaction dated Friday. The shares were purchased at an average price of $5.83 per ...
Related articles »  
Fast Moving Stocks: Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), Ericsson ...
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) belongs to Healthcare sector. Its net profit margin is -10.50% and weekly performance is 1.30%.
Related articles »  
Today's Stocks: Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), CTI BioPharma ...
On 4 AUG Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) said that it was graded by investment analysts at Guggenheim to a ´┐Żneutral´┐Ż rating in a note issued to investors on Monday.
Related articles »  
Investors Alert: Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), Baidu Inc (ADR ...
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced that it will present a poster describing preclinical data on BTA-C585, the Company's oral fusion inhibitor in development for the treatment of respiratory syncytial virus infections (RSV), at the 54th ...
Related articles »  
5 Stocks under Wall Street's Radar: ACADIA Pharmaceuticals Inc. (NASDAQ ...
On 1 AUG Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced top-line data from a randomized, double-blind, placebo-controlled, parallel-arm Phase 2 clinical trial comparing the safety and efficacy of a 40 mg and 80 mg dose of laninamivir octanoate ...
Related articles »  
Best Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), Hilton Worldwide ...
On August 1, Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) announced its experimental influenza drug failed to meet the main goal in a mid-stage study.